Your browser doesn't support javascript.
loading
COVID-19 Vaccine Response in People with Multiple Sclerosis.
Tallantyre, Emma C; Vickaryous, Nicola; Anderson, Valerie; Asardag, Aliye Nazli; Baker, David; Bestwick, Jonathan; Bramhall, Kath; Chance, Randy; Evangelou, Nikos; George, Katila; Giovannoni, Gavin; Godkin, Andrew; Grant, Leanne; Harding, Katharine E; Hibbert, Aimee; Ingram, Gillian; Jones, Meleri; Kang, Angray S; Loveless, Samantha; Moat, Stuart J; Robertson, Neil P; Schmierer, Klaus; Scurr, Martin J; Shah, Sita Navin; Simmons, Jessica; Upcott, Matthew; Willis, Mark; Jolles, Stephen; Dobson, Ruth.
Affiliation
  • Tallantyre EC; Division of Psychological Medicine and Clinical Neuroscience, School of Medicine, Cardiff University, Cardiff, UK.
  • Vickaryous N; Department of Neurology, University Hospital of Wales, Cardiff, UK.
  • Anderson V; Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University London, London, UK.
  • Asardag AN; Division of Psychological Medicine and Clinical Neuroscience, School of Medicine, Cardiff University, Cardiff, UK.
  • Baker D; Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Bestwick J; Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Bramhall K; Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University London, London, UK.
  • Chance R; Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, UK.
  • Evangelou N; Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • George K; Centre for Oral Immunobiology and Regenerative Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Giovannoni G; Department of Clinical Neurology, University of Nottingham, Nottingham, UK.
  • Godkin A; Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University London, London, UK.
  • Grant L; Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University London, London, UK.
  • Harding KE; Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Hibbert A; Department of Neurology, Barts Health NHS Trust, London, UK.
  • Ingram G; Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
  • Jones M; Department of Gastroenterology and Hepatology, University Hospital of Wales, Cardiff, UK.
  • Kang AS; Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, UK.
  • Loveless S; Department of Neurology, Royal Gwent Hospital, Newport, UK.
  • Moat SJ; Department of Clinical Neurology, University of Nottingham, Nottingham, UK.
  • Robertson NP; Department of Neurology, Morriston Hospital, Swansea, UK.
  • Schmierer K; Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Scurr MJ; Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Shah SN; Centre for Oral Immunobiology and Regenerative Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Simmons J; Division of Psychological Medicine and Clinical Neuroscience, School of Medicine, Cardiff University, Cardiff, UK.
  • Upcott M; Wales Newborn Screening Laboratory, Department of Medical Biochemistry, Immunology and Toxicology, University Hospital of Wales, Cardiff, UK.
  • Willis M; School of Medicine, Cardiff University, Cardiff, UK.
  • Jolles S; Division of Psychological Medicine and Clinical Neuroscience, School of Medicine, Cardiff University, Cardiff, UK.
  • Dobson R; Department of Neurology, University Hospital of Wales, Cardiff, UK.
Ann Neurol ; 91(1): 89-100, 2022 01.
Article in En | MEDLINE | ID: mdl-34687063

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunocompromised Host / Antirheumatic Agents / Seroconversion / COVID-19 Vaccines / COVID-19 / Multiple Sclerosis Type of study: Guideline / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Ann Neurol Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunocompromised Host / Antirheumatic Agents / Seroconversion / COVID-19 Vaccines / COVID-19 / Multiple Sclerosis Type of study: Guideline / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Ann Neurol Year: 2022 Document type: Article Affiliation country: Country of publication: